Colinz Laboratories Balance Sheet Annual

BSE: 531210 | NSE: - | ISIN: INE923C01011 | Sector: Biotechnology & Drugs

53.50 -1.52 (-2.76%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	2.95	1.97	2.09	1.39
Cash Equivalents	4.05	3.76	3.12	3.29
Cashand Short Term Investments	7.00	5.73	5.21	4.68
Accounts Receivable- Trade Net	0.86	1.13	1.21	1.30
Total Receivables Net	0.86	1.13	1.21	1.30
Total Inventory	0.85	0.94	0.93	1.25
Other Current Assets Total	0.03	0.03	0.04	0.05
Total Current Assets	8.74	7.84	7.38	7.27
Property/ Plant/ Equipment Total- Net	1.58	1.71	1.86	2.03
Long Term Investments	1.02	0.66	0.67	0.61
Note Receivable- Long Term	0.02	0.02	0.02	0.20
Total Assets	11.36	10.23	9.93	10.10
Accounts Payable	0.60	0.65	0.48	0.54
Notes Payable/ Short Term Debt	0.57	0.27	0.48	0.99
Other Currentliabilities Total	1.01	0.96	1.02	1.05
Total Current Liabilities	2.18	1.89	1.98	2.59
Total Debt	0.57	0.27	0.48	0.99
Deferred Income Tax	0.23	0.21	0.22	0.23
Other Liabilities Total	0.00	0.00	0.04	0.00
Total Liabilities	2.41	2.09	2.24	2.81
Common Stock Total	2.52	2.52	3.55	3.55
Retained Earnings( Accumulated Deficit)	6.43	5.62	4.14	3.75
Total Equity	8.95	8.14	7.69	7.29
Total Liabilities Shareholders' Equity	11.36	10.23	9.93	10.10
Total Common Shares Outstanding	0.25	0.25	0.46	0.46
Tangible Book Valueper Share Common Eq	35.52	32.31	16.82	15.95
Total Long Term Debt	-	0.00	0.00	-